Benign prostatic hyperplasia (BPH) is a prevalent urological condition that predominantly affects older men [1]. Around 20% of males over the age of 50 encounter urinary difficulties, and its occurrence rises considerably with age, affecting over 50% of men by 70 years old [2]. The 2019 Global Burden...
This podcast examines how hormone-sensitive prostate cancer (HSPC) is treated, specifically looking at therapies that target the androgen-sensitive pathway. Identification of patients and the clinical rationale for following different treatment...
Benign prostatic hyperplasia (BPH) is one of the common urological diseases in elderly men, and in recent years, with the accelerated aging of the population, the incidence of BPH has been increasing year by year [1]. It is reported that the number of BPH patients in China is expected to exceed 75 million...
Benign prostatic hyperplasia (BPH) affects approximately 50% of men over 50 years, increasing to 90% in men over 90, making it one of the most prevalent conditions in aging males [1, 2]. Many affected individuals develop significant lower urinary tract symptoms (LUTS), necessitating therapeutic interventions...